Capstan Therapeutics

Capstan Therapeutics combines the power of in vivo cell therapy with the precision of genetic medicines to develop new treatments for patients with cancer, fibrosis, inflammation-related diseases, and monogenic blood disorders. Our founders include the inventors of the first clinically approved CAR T and mRNA technologies, which have enabled RNA medicines.